“…All three values are without significant differences and indicate that 27·6–28·9% of pregnant women are susceptible. A recently published study determined a similar seroprevalence of 69·2% in women (17–45 years) in FWG [9] which is related to those reported from other European countries: studies in The Netherlands, Denmark, and Finland reported on slightly lower rates of 70%, 65–66% and 58·6% [27–30], whereas higher seroprevalences of 75·3% and 81·0% were found in Russia and Sweden, respectively [31, 32].…”